 Antigens, Neoplasm
"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
| Descriptor ID |
D000951
|
| MeSH Number(s) |
D23.050.285
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".
This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 0 | 6 | 6 | | 1998 | 2 | 3 | 5 | | 1999 | 1 | 2 | 3 | | 2000 | 3 | 1 | 4 | | 2001 | 1 | 7 | 8 | | 2002 | 3 | 5 | 8 | | 2003 | 2 | 2 | 4 | | 2004 | 1 | 0 | 1 | | 2005 | 4 | 4 | 8 | | 2006 | 5 | 2 | 7 | | 2007 | 5 | 2 | 7 | | 2008 | 6 | 4 | 10 | | 2009 | 3 | 2 | 5 | | 2010 | 5 | 1 | 6 | | 2011 | 2 | 3 | 5 | | 2012 | 2 | 2 | 4 | | 2013 | 7 | 7 | 14 | | 2014 | 7 | 3 | 10 | | 2015 | 3 | 2 | 5 | | 2016 | 13 | 4 | 17 | | 2017 | 7 | 6 | 13 | | 2018 | 8 | 5 | 13 | | 2019 | 9 | 2 | 11 | | 2020 | 9 | 4 | 13 | | 2021 | 7 | 3 | 10 | | 2022 | 2 | 5 | 7 | | 2023 | 4 | 6 | 10 | | 2024 | 4 | 8 | 12 | | 2025 | 3 | 4 | 7 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.
-
Garza B, Calhoun J, Norman PJ, Cline N, Kichula KM, Farias TDJ, Sams S, Boorgula MP, Danhorn T, Haugen BR, French JD. Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific Proteins and Neo-antigens in Follicular Cell-derived Thyroid Cancers. J Clin Endocrinol Metab. 2026 Apr 22; 111(5):e1289-e1301.
-
Lenkala D, Kohler J, McCarthy B, Nelson M, Bakker NAM, de Boer R, Jackson EK, Sheen JHF, Hannes S, Esaulova E, Stewart K, Gottstein C, Attanasio J, Brown FD, Hymson S, Meda S, van Zon M, Scheij S, Voogd R, Raud B, Xu Z, Borgers JSW, Rohaan MW, Balogh KN, Poran A, Rooney M, Dong JZ, Srouji JR, Juneja VR, Arieta CM, Nijenhuis CM, Nuijen B, DeMario M, Manson K, Schumacher TNM, Gaynor RB, Haanen JB, van den Berg JH, van Buuren MM. NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy. Nat Commun. 2026 Feb 05; 17(1).
-
Morton JJ, Ramos SA, Alzofon N, Keysar SB, Armitage LH, Baker AS, Barra JM, Chimed TS, Le PN, Nieto C, Weaver AN, Thomas CM, Miller B, Robinson W, Medina TM, Gao D, Russ HA, Jimeno A. Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts. Cancer Res Commun. 2025 Nov 01; 5(11):2053-2065.
-
Nagaoka K, Nakanishi H, Tanaka H, Anindita J, Kawamura T, Tanaka T, Yamashita T, Kuroda A, Nomura S, Akita H, Itaka K, Kodama T, Kakimi K. Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis. Gastric Cancer. 2025 09; 28(5):825-836.
-
Lowery FJ, Goff SL, Gasmi B, Parkhurst MR, Ratnam NM, Halas HK, Shelton TE, Langhan MM, Bhasin A, Dinerman AJ, Dulemba V, Goldlust IS, Gustafson AM, Hakim AA, Hitscherich KJ, Kenney LM, Levy L, Rault-Wang JG, Bera A, Ray S, Seavey CD, Hoang CD, Hernandez JM, Gartner JJ, Sindiri S, Prickett TD, McIntyre LS, Krishna S, Robbins PF, Klemen ND, Kwong MLM, Yang JC, Rosenberg SA. Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial. Nat Med. 2025 Jun; 31(6):1994-2003.
-
Cho BC, Johnson M, Bar J, Schaefer E, Yoh K, Zer A, Moskovitz M, Lee SH, Moreno V, de Miguel M, Okuma Y, Kim JH, Lee CH, Peguero J, Ansell P, Biesdorf C, Saab R, Freise KJ, Ramies D, Jeng EE, Camidge DR. A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer. Lung Cancer. 2025 Apr; 202:108492.
-
Zhang Y, Liu X, Shen T, Wang Q, Zhou S, Yang S, Liao S, Su T, Mei L, Zhang B, Huynh K, Xie L, Guo Y, Guo C, Tyc KM, Qu X, Wang XY, Liu J, Zhu G. Small circular RNAs as vaccines for cancer immunotherapy. Nat Biomed Eng. 2025 Feb; 9(2):249-267.
-
Leko V, Groh E, Levi ST, Copeland AR, White BS, Gasmi B, Li Y, Hill V, Gurusamy D, Levin N, Kim SP, Sindiri S, Gartner JJ, Prickett TD, Parkhust M, Lowery FJ, Goff SL, Rosenberg SA, Robbins P. Utilization of primary tumor samples for cancer neoantigen discovery. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR. Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial. Nat Med. 2025 Jan; 31(1):152-164.
-
Borgers JSW, Lenkala D, Kohler V, Jackson EK, Linssen MD, Hymson S, McCarthy B, O'Reilly Cosgrove E, Balogh KN, Esaulova E, Starr K, Ware Y, Klobuch S, Sciuto T, Chen X, Mahimkar G, Sheen JHF, Ramesh S, Wilgenhof S, van Thienen JV, Scheiner KC, Jedema I, Rooney M, Dong JZ, Srouji JR, Juneja VR, Arieta CM, Nuijen B, Gottstein C, Finney OC, Manson K, Nijenhuis CM, Gaynor RB, DeMario M, Haanen JB, van Buuren MM. Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial. Nat Med. 2025 Mar; 31(3):881-893.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|